BenzingaBenzinga Japan
BenzingaBenzinga Japan
BenzingaBenzinga Japan
土曜日, 9 26

Structure Therapeutics Inc

GPCRNASDAQ
Trade with Public
Trade with Public
$35.93
-0.09-0.25%
近くで: Sep 25, 5:00 PM EST
$35.96
0.030.08%
時間外: 4:00 PM EST
概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Structure Therapeutics Earnings & Forecasts

Structure Therapeutics (GPCR) earnings history, EPS estimates, revenue forecasts and company guidance.

Earnings Per Share (Non-GAAP)

Quarterly Revenue (Billions)

Structure Therapeutics Guidance

Recent Earnings Results

MetricQ2 '26Q1 '26Q4 '25Q3 '25
Earnings Per Share (Non-GAAP)
Estimate$-0.38$-0.33$-0.36$-0.36
Actual$-0.49$-0.35$-0.36$-0.37
Surprise-28.9%-6.06%0.00%-2.78%
Revenue
Estimate—$11.1M$200.0M—
Actual$0$0$0$0
Surprise—-100.0%-100.0%—
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
MetricQ3 '26EQ4 '26EQ1 '27EQ2 '27E
Earnings Per Share (Non-GAAP)
Consensus$-0.29$-0.49$-0.48$-0.50
Revenue
Consensus$50.0M———
More with Benzinga EdgeGet Access

Earnings & Guidance News

PRO
Structure Therapeutics Q1 EPS $(0.35), Inline

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.35) per share which met the analyst consensus estimate. This is a 29.63 percent decrease over losses of $(0.27) per share from the same period last
Benzinga Newsdesk

PRO
Structure Therapeutics Q4 Adj. EPS $(0.36) Beats $(0.40) Estimate.

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.36) per share which beat the analyst consensus estimate of $(0.40) by 9.09 percent. This is a 63.64 percent decrease over losses of $(0.22) per share
Benzinga Newsdesk

Crude Oil Falls Over 1%; Structure Therapeutics Shares Jump

Avi Kapoor

PRO
Structure Therapeutics Q2 EPS $(0.36) Misses $(0.25) Estimate

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.25) by 44 percent. This is a 100 percent decrease over losses of $(0.18) per share
Benzinga Newsdesk

PRO
Structure Therapeutics FY 2024 GAAP EPS $(0.78) Beats $(0.80) Estimate

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(0.80) by 2.5 percent. This is a 3.7 percent increase over losses of $(0.81) per share
Benzinga Newsdesk

PRO
Structure Therapeutics Q3 EPS $(0.20), Inline

Structure Therapeutics (NASDAQ:GPCR) reported quarterly losses of $(0.20) per share which met the analyst consensus estimate. This is a 4.76 percent increase over losses of $(0.21) per share from the same period last
Benzinga Newsdesk

データとAPI: Benzinga API · 株式ニュースAPI · アナリスト評価API · 企業ロゴAPI

BenzingaBenzinga Japan

ニュース

パートナーシップ

ベンジンガ・グローバル

© 2026 Benzinga | All Rights Reserved